M. Peck-Radosavljevic Et Al. , "Low-Dose Peginterferon Alfa-2a Is Safe and Produces a Sustained Virologic Response in Patients With Chronic Hepatitis C and End-Stage Renal Disease," Clinical Gastroenterology and Hepatology , vol.9, no.3, pp.242-248, 2011
Peck-Radosavljevic, M. Et Al. 2011. Low-Dose Peginterferon Alfa-2a Is Safe and Produces a Sustained Virologic Response in Patients With Chronic Hepatitis C and End-Stage Renal Disease. Clinical Gastroenterology and Hepatology , vol.9, no.3 , 242-248.
Peck-Radosavljevic, M., Boletis, J., Besisik, F., Ferraz, M. L., Alric, L., Samuel, D., ... Messinger, D.(2011). Low-Dose Peginterferon Alfa-2a Is Safe and Produces a Sustained Virologic Response in Patients With Chronic Hepatitis C and End-Stage Renal Disease. Clinical Gastroenterology and Hepatology , vol.9, no.3, 242-248.
Peck-Radosavljevic, Markus Et Al. "Low-Dose Peginterferon Alfa-2a Is Safe and Produces a Sustained Virologic Response in Patients With Chronic Hepatitis C and End-Stage Renal Disease," Clinical Gastroenterology and Hepatology , vol.9, no.3, 242-248, 2011
Peck-Radosavljevic, Markus Et Al. "Low-Dose Peginterferon Alfa-2a Is Safe and Produces a Sustained Virologic Response in Patients With Chronic Hepatitis C and End-Stage Renal Disease." Clinical Gastroenterology and Hepatology , vol.9, no.3, pp.242-248, 2011
Peck-Radosavljevic, M. Et Al. (2011) . "Low-Dose Peginterferon Alfa-2a Is Safe and Produces a Sustained Virologic Response in Patients With Chronic Hepatitis C and End-Stage Renal Disease." Clinical Gastroenterology and Hepatology , vol.9, no.3, pp.242-248.
@article{article, author={Markus Peck-Radosavljevic Et Al. }, title={Low-Dose Peginterferon Alfa-2a Is Safe and Produces a Sustained Virologic Response in Patients With Chronic Hepatitis C and End-Stage Renal Disease}, journal={Clinical Gastroenterology and Hepatology}, year=2011, pages={242-248} }